Literature DB >> 15509454

What do we (not) know about the management of blood pressure in acute stroke?

Annick Verstappen1, Vincent Thijs.   

Abstract

Although it is indisputable that high blood pressure should be treated to prevent a first or a recurrent stroke, the management of high blood pressure in the first hours and days after stroke remains controversial. There is no high-quality evidence from randomized controlled trials to guide treatment in the 80% of patients who have elevated blood pressure during the first days after stroke. Theoretically, there are pros and cons for manipulating blood pressure after onset of stroke. Most treatment guidelines suggest leaving blood pressure untouched based on pathophysiologic principles. Post-hoc analyses from randomized trials, however, suggest that elevated blood pressure is associated with recurrent stroke and higher mortality, even after adjustment for potential confounders. On the other hand, preliminary studies have suggested that voluntarily increasing blood pressure might be beneficial in a selected subgroup of patients. In this overview, we present a summary of recent studies on this topic.

Entities:  

Mesh:

Year:  2004        PMID: 15509454     DOI: 10.1007/s11910-004-0076-7

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  38 in total

1.  Induced elevation of blood pressure in the acute phase of ischemic stroke in humans.

Authors:  R Saxena; A D Wijnhoud; P J Koudstaal; A H van Den Meiracker
Journal:  Stroke       Date:  2000-02       Impact factor: 7.914

Review 2.  Interventions for deliberately altering blood pressure in acute stroke.

Authors: 
Journal:  Cochrane Database Syst Rev       Date:  2001

3.  Blood pressure and clinical outcomes in the International Stroke Trial.

Authors:  Jo Leonardi-Bee; Philip M W Bath; Stephen J Phillips; Peter A G Sandercock
Journal:  Stroke       Date:  2002-05       Impact factor: 7.914

4.  Perindopril reduces blood pressure but not cerebral blood flow in patients with recent cerebral ischemic stroke.

Authors:  A G Dyker; D G Grosset; K Lees
Journal:  Stroke       Date:  1997-03       Impact factor: 7.914

5.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

6.  Hypertension and its treatment in the NINDS rt-PA Stroke Trial.

Authors:  T Brott; M Lu; R Kothari; S C Fagan; M Frankel; J C Grotta; J Broderick; T Kwiatkowski; C Lewandowski; E C Haley; J R Marler; B C Tilley
Journal:  Stroke       Date:  1998-08       Impact factor: 7.914

7.  The prognostic value of admission blood pressure in patients with acute stroke.

Authors:  B Carlberg; K Asplund; E Hägg
Journal:  Stroke       Date:  1993-09       Impact factor: 7.914

8.  Effect of blood pressure during the acute period of ischemic stroke on stroke outcome: a tertiary analysis of the GAIN International Trial.

Authors:  Stella Aslanyan; Franz Fazekas; Christopher J Weir; Susanna Horner; Kennedy R Lees
Journal:  Stroke       Date:  2003-09-18       Impact factor: 7.914

9.  Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome.

Authors:  José Castillo; Rogelio Leira; María M García; Joaquín Serena; Miguel Blanco; Antoni Dávalos
Journal:  Stroke       Date:  2004-01-15       Impact factor: 7.914

Review 10.  High blood pressure in acute stroke and subsequent outcome: a systematic review.

Authors:  Mark Willmot; Jo Leonardi-Bee; Philip M W Bath
Journal:  Hypertension       Date:  2003-12-08       Impact factor: 10.190

View more
  1 in total

Review 1.  Treatment of massive cerebral infarction.

Authors:  David Palestrant; Jennifer A Frontera; Stephan A Mayer
Journal:  Curr Neurol Neurosci Rep       Date:  2005-11       Impact factor: 5.081

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.